Terbutaline impairs the development of peripheral noradrenergic projections: Potential implications for autism spectrum disorders and pharmacotherapy of preterm labor

Neurotoxicology and Teratology

Volumn 36, Issue , 2013, Pages 91-96

  Slotkin, Theodore A ^a   Seidler, Frederic J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adrenergic agonists; Autism; Norepinephrine; Preterm delivery; Sympathetic nervous system; Terbutaline

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; NORADRENALIN; TERBUTALINE SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; AUTONOMIC DYSFUNCTION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; MALE; NERVE PROJECTION; NEUROTOXICITY; NONHUMAN; NORADRENERGIC SYSTEM; POSTSYNAPTIC POTENTIAL; PREMATURE LABOR; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; SYMPATHETIC TONE;

ANIMALS; ANIMALS, NEWBORN; AUTISTIC DISORDER; FEMALE; MALE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; TERBUTALINE;

RATTUS;

EID: 84875653369     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2012.07.003     Document Type: Article

References (68)

1. Anderson C.J., Colombo J., Unruh K.E. Pupil and salivary indicators of autonomic dysfunction in autism spectrum disorder. Dev Psychobiol 2012, 10.1002/dev.21051.
2. Auman J.T., Seidler F.J., Slotkin T.A. Regulation of fetal cardiac and hepatic β-adrenoceptors and adenylyl cyclase signaling: terbutaline effects. Am J Physiol 2001, 281:R1079-R1089.
3. Auman J.T., Seidler F.J., Tate C.A., Slotkin T.A. β-Adrenoceptor-mediated cell signaling in the neonatal heart and liver: responses to terbutaline. Am J Physiol 2001, 281:R1895-R1901.
4. Azevedo I., Osswald W. Trophic role of the sympathetic innervation. J Pharmacol 1986, 17:30-43.
5. Bareis D.L., Slotkin T.A. Responses of heart ornithine decarboxylase and adrenal catecholamines to methadone and sympathetic stimulants in developing and adult rats. J Pharmacol Exp Ther 1978, 205:164-174.
6. Bartolome J., Lau C., Slotkin T.A. Ornithine decarboxylase in developing rat heart and brain: role of sympathetic development for responses to autonomic stimulants and the effects of reserpine on maturation. J Pharmacol Exp Ther 1977, 202:510-518.
7. Bartolome J., Grignolo A., Bartolome M., Trepanier P., Lerea L., Weigel S., et al. Postnatal methyl mercury exposure: effects on ontogeny of renal and hepatic ornithine decarboxylase responses to trophic stimuli. Toxicol Appl Pharmacol 1985, 80:147-154.
8. Black I.B. Developmental regulation of neurotransmitter phenotype. Curr Top Dev Biol 1980, 15:27-40.
9. Black I.B., Bloom E.M., Hamill R.W. Central regulation of sympathetic neuron development. Proc Natl Acad Sci U S A 1976, 73:3575-3578.
10. Bruel-Jungerman E., Lucassen P.J., Francis F. Cholinergic influences on cortical development and adult neurogenesis. Behav Brain Res 2011, 221:379-388.
11. Buznikov G.A., Shmukler Y.B., Lauder J.M. From oocyte to neuron: do neurotransmitters function in the same way throughout development?. Cell Mol Neurobiol 1996, 16:532-559.
12. Buznikov G.A., Nikitina L.A., Bezuglov V.V., Francisco M.E., Obispo-Peak I.N., Peterson R.A., et al. New perspectives on roles for neurotransmitters in early ("pre-nervous") embryogenesis. Neurobiological studies - from genes to behaviour 2007, 183-196. Signpost/Transworld Research Network, Kerala, India. S. Ruždijić, L. Rakić (Eds.).
13. Cheslack-Postava K., Fallin M.D., Avramopoulos D., Connors S.L., Zimmerman A.W., Eberhart C.G., et al. β2-Adrenergic receptor gene variants and risk for autism in the AGRE cohort. Mol Psychiatry 2007, 12:283-291.
14. i-dependent coupling to phosphatidylinositol 3'-kinase. Circ Res 2000, 87:1172-1179.
15. 2-adrenergic receptor signaling and autism: dysmaturation and retained fetal function. Autism: Current Theories and Evidence 2008, 147-182. Humana Press, Totowa NJ. A.W. Zimmerman (Ed.).
16. 2-Adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins. J Child Neurol 2005, 20:876-884.
17. 2-adrenergic receptor agonists and risk of autism spectrum disorders. J Neurodev Disord 2011, 3:307-315.
18. Dibner M.D., Mytilineou C., Black I.B. Target organ regulation of sympathetic neuron development. Brain Res 1977, 123:301-310.
19. Exton J.H. Mechanisms involved in α-adrenergic effects of catecholamines on liver metabolism. J Cyclic Nucleotide Res 1979, 5:277-287.
20. Fan X., Miles J.H., Takahashi N., Yao G. Abnormal transient pupillary light reflex in individuals with autism spectrum disorders. J Autism Dev Disord 2009, 39:1499-1508.
21. Feenstra M.G.P. Functional neuroteratology of drugs acting on adrenergic receptors. Neurotoxicology 1992, 13:55-63.
22. Fu Y.C., Chi C.S., Yin S.C., Hwang B., Chiu Y.T., Hsu S.L. Norepinephrine induces apoptosis in neonatal rat endothelial cells via down-regulation of Bcl-2 and activation of beta-adrenergic and caspase-2 pathways. Cardiovasc Res 2004, 61:143-151.
23. Garofolo M.C., Seidler F.J., Cousins M.M., Tate C.A., Qiao D., Slotkin T.A. Developmental toxicity of terbutaline: critical periods for sex-selective effects on macromolecules and DNA synthesis in rat brain, heart, and liver. Brain Res Bull 2003, 59:319-329.
24. Giannuzzi C.E., Seidler F.J., Slotkin T.A. β-Adrenoceptor control of cardiac adenylyl cyclase during development: agonist pretreatment in the neonate uniquely causes heterologous sensitization, not desensitization. Brain Res 1995, 694:271-278.
25. Goldenberg R.L. The management of preterm labor. Obstet Gynecol 2002, 100:1020-1037.
26. Grandjean P., Landrigan P.J. Developmental neurotoxicity of industrial chemicals. Lancet 2006, 368:2167-2178.
27. Hadders-Algra M., Touwen B.C., Huisjes H.J. Long-term follow-up of children prenatally exposed to ritodrine. Br J Obstet Gynaecol 1986, 93:156-161.
28. Hirstein W., Iversen P., Ramachandran V.S. Autonomic responses of autistic children to people and objects. Proc R Soc Lond B 2001, 268:1883-1888.
29. Hou Q.-C., Slotkin T.A. Effects of prenatal dexamethasone or terbutaline exposure on development of neural and intrinsic control of heart rate. Pediatr Res 1989, 26:554-557.
30. Hou Q.-C., Baker F.E., Seidler F.J., Bartolome M., Bartolome J., Slotkin T.A. Role of sympathetic neurons in development of β-adrenergic control of ornithine decarboxylase activity in peripheral tissues: effects of neonatal 6-hydroxydopamine treatment. J Dev Physiol 1989, 11:139-146.
31. Hou Q.-C., Seidler F.J., Slotkin T.A. Development of the linkage of β-adrenergic receptors to cardiac hypertrophy and heart rate control: neonatal sympathectomy with 6-hydroxydopamine. J Dev Physiol 1989, 11:305-311.
32. Katz M.S., Boland S.R., Schmidt S.J. Developmental changes of β-adrenergic receptor-linked adenylate cyclase of rat liver. Am J Physiol 1985, 248:E712-E718.
33. Kilburn K.H., Thrasher J.D., Immers N.B. Do terbutaline- and mold-associated impairments of the brain and lung relate to autism?. Toxicol Ind Health 2009, 25:703-710.
34. 2-adrenoceptors in brain and peripheral tissues: mechanisms underlying the developmental toxicity of terbutaline. Brain Res Bull 2004, 62:305-314.
35. Kudlacz E.M., Navarro H.A., Eylers J.P., Lappi S.E., Dobbins S.S., Slotkin T.A. Effects of prenatal terbutaline exposure on cellular development in lung and liver of neonatal rat: ornithine decarboxylase activity and macromolecules. Pediatr Res 1989, 25:617-622.
36. Lam F., Bergauer N.K., Jacques D., Coleman S.K., Stanziano G.J. Clinical and cost-effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for treatment of recurrent preterm labor in twin gestations. J Perinatol 2001, 21:444-450.
37. Lauder J.M. Roles for neurotransmitters in development: possible interaction with drugs during the fetal and neonatal periods. Prevention of physical and mental congenital defects 1985, 375-380. Alan R. Liss, New York. M. Marois (Ed.).
38. McMillian M.K., Schanberg S.M., Kuhn C.M. Ontogeny of rat hepatic adrenoceptors. J Pharmacol Exp Ther 1983, 227:181-186.
39. Morris G., Slotkin T.A. Beta-2 adrenergic control of ornithine decarboxylase activity in brain regions of the developing rat. J Pharmacol Exp Ther 1985, 233:141-147.
40. Navarro H.A., Kudlacz E.M., Kavlock R.J., Slotkin T.A. Prenatal terbutaline treatment: tissue-selective dissociation of perinatal changes in β-adrenergic receptor binding from regulation of adenylate cyclase activity. Life Sci 1991, 48:269-274.
41. Pitzer M., Schmidt M.H., Esser G., Laucht M. Child development after maternal tocolysis with β-sympathomimetic drugs. Child Psychiatry Hum Dev 2001, 31:165-182.
42. Rhodes M.C., Seidler F.J., Abdel-Rahman A., Tate C.A., Nyska A., Rincavage H.L., et al. Terbutaline is a developmental neurotoxicant: effects on neuroproteins and morphology in cerebellum, hippocampus and somatosensory cortex. J Pharmacol Exp Ther 2004, 308:529-537.
43. Robinson B.V., Ettedgui J.A., Sherman F.S. Use of terbutaline in the treatment of complete heart block in the fetus. Cardiol Young 2001, 11:683-686.
44. Rodier P.M. Structural-functional relationships in experimentally induced brain damage. Prog Brain Res 1988, 73:335-348.
45. 2 adrenergic receptor development. Neuroscience 2011, 192:761-772.
46. Seidler F.J., Slotkin T.A. Presynaptic and postsynaptic contributions to ontogeny of sympathetic control of heart rate in the preweanling rat. Br J Pharmacol 1979, 65:431-434.
47. Seidler F.J., Slotkin T.A. Development of central control of norepinephrine turnover and release in the rat heart: responses to tyramine, 2-deoxyglucose and hydralazine. Neuroscience 1981, 6:2081-2086.
48. Shizukuda Y., Buttrick P.M. Subtype specific roles of β-adrenergic receptors in apoptosis of adult rat ventricular myocytes. J Mol Cell Cardiol 2002, 34:823-831.
49. Slotkin T.A. Endocrine control of synaptic development in the sympathetic nervous system: the cardiac-sympathetic axis. Developmental neurobiology of the autonomic nervous system 1986, 97-133. Humana Press, Clifton, NJ. P.M. Gootman (Ed.).
50. Slotkin T.A., Seidler F.J. Anomalous regulation of β-adrenoceptor signaling in brain regions of the newborn rat. Brain Res 2006, 1077:54-58.
51. Slotkin T.A., Kavlock R.J., Cowdery T., Orband L., Bartolome M., Gray J.A., et al. Functional consequences of prenatal methylmercury exposure: effects on renal and hepatic responses to trophic stimuli and on renal excretory mechanisms. Toxicol Lett 1986, 34:231-245.
52. Slotkin T.A., Baker F.E., Dobbins S.S., Eylers J.P., Lappi S.E., Seidler F.J. Prenatal terbutaline exposure in the rat: selective effects on development of noradrenergic projections to cerebellum. Brain Res Bull 1989, 23:263-265.
53. Slotkin T.A., Kudlacz E.M., Lappi S.E., Tayyeb M.I., Seidler F.J. Fetal terbutaline exposure causes selective postnatal increases in cerebellar α-adrenergic receptor binding. Life Sci 1990, 47:2051-2057.
54. Slotkin T.A., Lorber B.A., McCook E.C., Barnes G.A., Seidler F.J. Neural input and the development of adrenergic intracellular signaling: neonatal denervation evokes neither receptor upregulation nor persistent supersensitivity of adenylate cyclase. Dev Brain Res 1995, 88:17-29.
55. Slotkin T.A., Saleh J.L., Zhang J., Seidler F.J. Ontogeny of β-adrenoceptor/adenylyl cyclase desensitization mechanisms: the role of neonatal innervation. Brain Res 1996, 742:317-328.
56. Slotkin T.A., Tate C.A., Cousins M.M., Seidler F.J. β-Adrenoceptor signaling in the developing brain: sensitization or desensitization in response to terbutaline. Dev Brain Res 2001, 131:113-125.
57. Slotkin T.A., Auman J.T., Seidler F.J. Ontogenesis of β-adrenoceptor signaling: implications for perinatal physiology and for fetal effects of tocolytic drugs. J Pharmacol Exp Ther 2003, 306:1-7.
58. Slotkin T.A., Tate C.A., Cousins M.M., Seidler F.J. Imbalances emerge in cardiac autonomic cell signaling after neonatal exposure to terbutaline or chlorpyrifos, alone or in combination. Dev Brain Res 2005, 260:219-230.
59. Tegner K., Nilsson H.T., Persson C.G.A., Persson K., Ryrfeldt Å. Elimination pathways of terbutaline. Eur J Respir Dis 1984, 65(Suppl. 134):93-100.
60. Thai L., Galluzzo J.M., McCook E.C., Seidler F.J., Slotkin T.A. Atypical regulation of hepatic adenylyl cyclase and adrenergic receptors during a critical developmental period: agonists evoke supersensitivity accompanied by failure of receptor downregulation. Pediatr Res 1996, 39:697-707.
61. Thornton J.G. Maintenance tocolysis. Br J Obstet Gynæacol 2005, 1:118-121.
62. U.S.Food and Drug Administration FDA Drug Safety Communication: New warnings against use of terbutaline to treat preterm labor [accessed 18 May 2012]. http://www.fda.gov/drugs/drugsafety/ucm243539.htm.
63. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2004, 57:67-81.
64. Whitaker-Azmitia P.M. Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology. Pharmacol Rev 1991, 43:553-561.
65. 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes. Am J Obstet Gynecol 2009, 201:553-559.
66. Yan L.Z., Herrmann V., Hofer J.K., Insel P.A. β-Adrenergic receptor/cAMP-mediated signaling and apoptosis of S49 lymphoma cells. Am J Physiol 2000, 279:C1665-C1674.
67. Zaugg M., Xu W.M., Lucchinetti E., Shafiq S.A., Jamali N.Z., Siddiqui M.A.Q. β-Adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 2000, 102:344-350.
68. Zerrate M.C., Pletnikov M., Connors S.L., Vargas D.L., Seidler F.J., Zimmerman A.W., et al. Neuroinflammation and behavioral abnormalities after neonatal terbutaline treatment in rats: implications for autism. J Pharmacol Exp Ther 2007, 322:16-22.